AVENUE THERAPEUTICS, INC. (ATXI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 500K 1M 1.5M Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 1.4M Q3 '25: 0 Q4 '25: 0 Q2 '26: 0 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '24: -3.2M Q4 '24: -1.6M Q1 '25: -1.9M Q2 '25: 297K Q3 '25: -724K Q4 '25: -752K Q1 '26: -714K Q2 '26: -707K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '24: -3.1M Q4 '24: -1.5M Q1 '25: -1.9M Q2 '25: 335K Q3 '25: -683K Q4 '25: -709K Q1 '26: -695K Q2 '26: -690K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-3M -2M -1M 0 1M 2M 3M Q3 '24: -2.9M Q4 '24: -764K Q1 '25: -1.2M Q2 '25: -176K Q3 '25: 383K Q4 '25: -854K Q1 '26: -438K Q2 '26: -475K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 1.5M 3M 4.5M Q1 '24: 562K Q2 '24: 1.1M Q3 '24: 1.6M Q1 '25: 3M Q2 '25: 3.2M Q3 '25: 3.2M Q1 '26: 3.3M Q2 '26: 3.3M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-30.00 -15.00 0.00 15.00 30.00 45.00 Q3 '24: 43.02 Q4 '24: -15.79 Q1 '25: -1.01 Q2 '25: 5.53 Q3 '25: 7.24 Q4 '25: -0.94 Q1 '26: -0.53 Q2 '26: -0.85 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.